Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02405221
Title Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

cervical cancer

Therapies

TA-CIN

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.